Differentiation of patented crystalline glucosamine sulfate from other glucosamine preparations will optimize osteoarthritis treatment
© 2017 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd Symptomatic slow-acting drugs for osteoarthritis (SYSADOAs) are recommended for the medium- to long-term management of knee osteoarthritis (OA) due to their abilities to control pain, improve funct...
Saved in:
Main Authors: | Sukit Saengnipanthkul, Saranatra Waikakul, Sattaya Rojanasthien, Kitti Totemchokchyakarn, Attarit Srinkapaibulaya, Tai Cheh Chin, Nguyen Mai Hong, Olivier Bruyère, Cyrus Cooper, Jean Yves Reginster, Myat Lwin |
---|---|
Other Authors: | Bach Mai Hospital |
Format: | Review |
Published: |
2020
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/51842 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Differentiation of patented crystalline glucosamine sulfate from other glucosamine preparations will optimize osteoarthritis treatment
by: Sukit Saengnipanthkul, et al.
Published: (2019) -
Budget impact analysis : an illustrative case of glucosamine in knee osteoarthritis
by: Jittrakul Leartsakulpanitch
Published: (2010) -
Efficacy of glucosamine plus diacerein versus monotherapy of glucosamine: A double-blind, parallel randomized clinical trial
by: Jatupon Kongtharvonskul, et al.
Published: (2018) -
Glucosamine long-term treatment and the progression of knee osteoarthritis: Systematic review of randomized controlled trials
by: Nalinee Poolsup, et al.
Published: (2018) -
Attenuation of IL-1ß on the use of glucosamine as an adjuvant in meloxicam treatment in rat models with osteoarthritis
by: Junaidi Khotib, -, et al.
Published: (2020)